HCA Healthcare (NYSE:HCA) Downgraded to “Market Perform” Rating by Raymond James

HCA Healthcare (NYSE:HCA) was downgraded by equities researchers at Raymond James from an “outperform” rating to a “market perform” rating in a report released on Friday,Briefing.com Automated Import reports.

Several other equities research analysts have also commented on HCA. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. UBS Group increased their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Royal Bank of Canada increased their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. KeyCorp reduced their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, Truist Financial increased their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Six research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Trading Down 0.2 %

NYSE:HCA opened at $332.22 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $84.15 billion, a price-to-earnings ratio of 14.92, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. HCA Healthcare has a 52 week low of $245.84 and a 52 week high of $417.14. The firm has a 50-day moving average price of $380.80 and a two-hundred day moving average price of $357.94.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock worth $5,608,990 in the last 90 days. 1.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. CreativeOne Wealth LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at approximately $231,000. Swedbank AB bought a new position in HCA Healthcare in the first quarter worth approximately $95,882,000. EP Wealth Advisors LLC raised its position in HCA Healthcare by 1.6% in the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after acquiring an additional 3,516 shares during the period. AustralianSuper Pty Ltd raised its position in HCA Healthcare by 118.5% in the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company’s stock worth $14,425,000 after acquiring an additional 19,247 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of HCA Healthcare by 3.3% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 162,654 shares of the company’s stock worth $52,257,000 after purchasing an additional 5,136 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.